ANGPT2: Angiopoietin-2
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling.
- Drugs that act on it: 8
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Faricimab | Approved | Angiopoietin-2 inhibitor | Inhibitor | — |
| AMG-780 | — | Angiopoietin-2 inhibitor | Inhibitor | — |
| CVX-060 | — | Angiopoietin-2 inhibitor | Inhibitor | — |
| MEDI-3617 | — | Angiopoietin-2 inhibitor | Inhibitor | — |
| Nesvacumab | — | Angiopoietin-2 inhibitor | Inhibitor | — |
| Trebananib | — | Angiopoietin-2 inhibitor | Inhibitor | — |
| Vanucizumab | — | Angiopoietin-2 inhibitor | Inhibitor | — |
| Zansecimab | — | Angiopoietin-2 inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Lymphatic malformation 10
- 0.62
- Microcephaly 1, primary, autosomal recessive
- 0.48
- Macular retinal edema
- 0.46
- Hemorrhoid
- 0.42
- Abnormality of the skeletal system
- 0.39
- Hydrops fetalis
- 0.38
- Non-immune hydrops fetalis
- 0.38
- Hypertensive disorder
- 0.38
- Ocular vascular disorder
- 0.37
- Cystoid macular edema
- 0.37
Drugs and mechanisms are from ChEMBL CHEMBL3580489 (CC BY-SA 3.0). Gene name, function (UniProt O15123, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets